These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33228229)
1. Comparison of Exosomes Derived from Non- and Gamma-Irradiated Melanoma Cancer Cells as a Potential Antigenic and Immunogenic Source for Dendritic Cell-Based Immunotherapeutic Vaccine. Kim WS; Choi D; Park JM; Song HY; Seo HS; Lee DE; Byun EB Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33228229 [TBL] [Abstract][Full Text] [Related]
2. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory. Hao S; Yuan J; Xiang J J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150 [TBL] [Abstract][Full Text] [Related]
3. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4 Cui X; Wang S; Zhao N; Wang S; Wang Z; Huang M; Liu Y; Qin J; Shan Z; Teng W; Li Y Mol Cell Endocrinol; 2020 Apr; 506():110756. PubMed ID: 32045626 [TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity. Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346 [TBL] [Abstract][Full Text] [Related]
7. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. Dai S; Zhou X; Wang B; Wang Q; Fu Y; Chen T; Wan T; Yu Y; Cao X J Mol Med (Berl); 2006 Dec; 84(12):1067-76. PubMed ID: 17016692 [TBL] [Abstract][Full Text] [Related]
8. Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets. Romagnoli GG; Zelante BB; Toniolo PA; Migliori IK; Barbuto JA Front Immunol; 2014; 5():692. PubMed ID: 25646096 [TBL] [Abstract][Full Text] [Related]
9. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588 [TBL] [Abstract][Full Text] [Related]
10. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Hao S; Bai O; Yuan J; Qureshi M; Xiang J Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501 [TBL] [Abstract][Full Text] [Related]
12. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities. Yao Y; Chen L; Wei W; Deng X; Ma L; Hao S Biochem Biophys Res Commun; 2013 Jun; 436(1):60-5. PubMed ID: 23707941 [TBL] [Abstract][Full Text] [Related]
13. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy. Shimizu K; Kuriyama H; Kjaergaard J; Lee W; Tanaka H; Shu S J Immunother; 2004; 27(4):265-72. PubMed ID: 15235387 [TBL] [Abstract][Full Text] [Related]
15. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. Schülke S Front Immunol; 2018; 9():455. PubMed ID: 29616018 [TBL] [Abstract][Full Text] [Related]
16. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292 [TBL] [Abstract][Full Text] [Related]
18. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399 [TBL] [Abstract][Full Text] [Related]
19. The immunogenicity of dendritic cell-derived exosomes. Quah BJ; O'Neill HC Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838 [TBL] [Abstract][Full Text] [Related]
20. IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. Vujanovic L; Ranieri E; Gambotto A; Olson WC; Kirkwood JM; Storkus WJ Cancer Gene Ther; 2006 Aug; 13(8):798-805. PubMed ID: 16645618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]